SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-145002
Filing Date
2021-04-30
Accepted
2021-04-30 16:06:52
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d176439ddefa14a.htm DEFA14A 19878
2 GRAPHIC g176439t1.jpg GRAPHIC 138962
3 GRAPHIC g176439t2.jpg GRAPHIC 93249
  Complete submission text file 0001193125-21-145002.txt   341040
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38443 | Film No.: 21877889
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences